Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
Imfinzi Approved in the US as First and Only Immunotherapy Regimen for Patients with Limited-Stage Small Cell Lung Cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC)...
FDA Grants Accelerated Approval to Bizengri (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) [Merus, the Company, we, or our], a clinical-stage...
Health Span-Lifespan Gaps Widening Globally
Health span-lifespan gaps, resulting from health-adjusted life expectancy lagging behind longevity gains, are growing worldwide, with women exhibiting...
Prostate Cancer Incidence, Mortality Rates Mainly Stable, Decreasing
In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period, but increasing trends were...
Elevated Blood Pressure Variability Linked to Lower Cognitive Scores
Elevated blood pressure variability (BPV), especially in older Black adults, is associated with lower cognitive scores, according to a study published...
2019 to 2022 Saw Increase in E-Scooter/Bike-Related Injury ED Visits
From 2019 to 2022, there was an increase in electric-powered scooter and bike (e-scooter/bike)-related injuries resulting in emergency department visits,...
Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio® (abemaciclib) in Patients with ER+, HER2- Advanced Breast Cancer
Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 EMBER-3 study of imlunestrant, an investigational, oral selective estrogen receptor...
Jamie Foxx Reveals He Had Brain Bleed in 2023
Actor Jamie Foxx has shared the details of a life-threatening medical emergency he experienced last year after doctors discovered he had suffered a brain...
Bird Flu in California Child Similar to Strain Seen in Livestock
As an outbreak of bird flu among dairy cows continues, U.S. health officials reported Tuesday that the strain of bird flu detected in a California child...
Women With Cancer Can Safely Use Rogaine to Curb Hair Loss
Women worried about losing their locks during chemotherapy can safely take hair-loss drugs during breast cancer care, a new study says. Minoxidil - the...
What Works Best to Help Young Vapers Quit?
Many young adults can kick their vaping habit with a little coaching and support. New research published Dec. 10 in the American Journal of Preventive...
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain
The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox...
Everything You Need to Know About Shingles & the Shingles Vaccine
Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior. Here,...
Recently Added
Recently added consumer and prescribing information: Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi, Imuldosa, Hympavzi, Flyrcado, Otulfi, Tecentriq Hybreza
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Bizengri Bizengri (zenocutuzumab-zbco) is a bispecific HER2- and HER3-directed antibody for the treatment of patients with neuregulin 1 fusion...
- Yesintek Yesintek (ustekinumab-kfce) is a human interleukin-12 and -23 antagonist biosimilar to Stelara used for the treatment of plaque psoriasis...
- Rapiblyk Rapiblyk (landiolol) is an ultra-short acting cardioselective beta-1 adrenergic blocker for for the short-term reduction of ventricular...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...